Quick Answer
ImageneBio, Inc. reported Total Assets of $152.98 million for fiscal year 2025.
ImageneBio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $152.98M | +860.8% |
| 2024 | $15.92M | -91.7% |
| 2023 | $192.09M | +11.5% |
| 2022 | $172.26M | -30.5% |
| 2021 | $247.88M | +47.2% |
| 2020 | $168.40M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $160.88M | +8.0% | +27.5% |
| June 30, 2025 | $126.17M | -19.9% | -3.6% |
| March 31, 2025 | $130.84M | -24.3% | +721.7% |
| December 31, 2024 | $15.92M | -91.7% | -89.3% |
| September 30, 2024 | $148.99M | -30.8% | -5.4% |
| June 30, 2024 | $157.49M | -8.3% | -8.9% |
| March 31, 2024 | $172.78M | +13.4% | -10.1% |
| December 31, 2023 | $192.09M | +11.5% | -10.8% |
- ImageneBio, Inc. showed an increase of +860.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, ImageneBio, Inc.’s total assets has declined by 9.2% (from $168.40 million to $152.98 million).
- The most recent figure is from ImageneBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: